Brello Price: How Telehealth GLP-1 Cost Is Built and What Drives It

This guide is part of the PlexusDx Education Hub, where we cover GLP-1 therapies, weight-management protocols, and the genetics that shape metabolic decisions. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Brello or its parent company, and no affiliate links or compensation are involved.

If you are pricing out Brello, the useful question is not a single headline number — it is how the cost is built. This review breaks down what drives a telehealth GLP-1 bill, why brand and compounded routes differ, and how cash-pay works, then contrasts it with PlexusDx's transparent pricing. Fair-balance context, as of April 2026.

How telehealth GLP-1 pricing is built

Brello (Brello Health) publishes its pricing on its own site, and the figure you see is a bundle: a clinical evaluation, the medication itself, and ongoing follow-up. Because Brello operates a telehealth-plus-compounded-pharmacy model, a prescription may route to a retail pharmacy for an FDA-approved brand or to a 503A compounding pharmacy for a compounded formulation — and that choice sits at the center of what you pay.

What drives your monthly total

Three levers move the number: which product you take (semaglutide versus tirzepatide versus another), your subscription tier, and brand-versus-compounded dispensing. Across the telehealth GLP-1 market, monthly totals as of April 2026 span roughly $200 to $700 or more, with wide variance. Because these figures change often, confirm Brello's current pricing on its official site before committing.

Brand vs. compounded and the cost gap

FDA-approved brand GLP-1 products and compounded formulations from 503A pharmacies carry different price structures, which is the main reason quotes vary so widely. The program flow is otherwise standard: intake covering weight, medical history, and medications; clinician review and eligibility; prescription routed to the appropriate pharmacy; and follow-up for titration. Provider type and pharmacy partner add further variation.

Cash-pay reality and insurance

Compounded telehealth GLP-1 programs generally operate on a cash-pay basis rather than billing insurance, so the posted subscription is typically your out-of-pocket cost. By contrast, PlexusDx prices its own protocols transparently and MTM-first: Semaglutide Injection at $189/mo and Tirzepatide Injection at $289/mo, with a Microdose option at $129/mo flat. The Precision Peptide Genetic Test is $298.

Spending smart: the genetic step before the subscription

Before any subscription, one input most programs skip is your genetics. Variants in FTO (fat-mass and obesity-associated), GLP1R (the GLP-1 receptor gene targeted by every GLP-1 compound), MC4R (a satiety-linked melanocortin receptor), and TCF7L2 (a glucose-homeostasis transcription factor) map your baseline metabolic terrain. They are pathway-level, not response predictors — but they describe the biology any protocol enters, which is worth understanding before you commit dollars.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — FTO, MC4R, and TCF7L2 included — so you spend from an informed baseline. That is the test before you invest approach.

Not affiliated: PlexusDx is not affiliated with Brello and has no commercial relationship with the companies reviewed in this article.

Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.

Disclaimer: This article is educational. PlexusDx is not affiliated with Brello and has no commercial relationship with the companies reviewed; it offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare pricing transparently: see the Weight Management Protocols for MTM-first semaglutide and tirzepatide, or start with the Precision Peptide Genetic Test to understand your GLP-1 pathway before you subscribe.

Frequently Asked Questions

How much does Brello cost per month?

Brello publishes its pricing on its own site, and it changes over time. Telehealth GLP-1 programs typically range from about $200 to $700 or more per month as of April 2026, depending on medication, subscription tier, and dispensing pathway. Verify the current figure on the brand's site before committing.

What is included in a telehealth GLP-1 subscription?

A subscription usually bundles the clinical evaluation, the prescribed medication, and follow-up visits for titration and side-effect support. What varies is whether the medication is an FDA-approved brand or a compounded formulation, plus the subscription tier. Check Brello's site for exactly what its plan includes.

Does insurance cover compounded telehealth GLP-1 programs?

Compounded telehealth GLP-1 programs generally run cash-pay and do not bill insurance, so the posted subscription is typically your out-of-pocket cost. Coverage for FDA-approved brand products through traditional channels is a separate question you would confirm with your insurer.

How does PlexusDx pricing compare?

PlexusDx prices transparently and MTM-first: Semaglutide Injection at $189/mo, Tirzepatide Injection at $289/mo, and a Microdose option at $129/mo flat. The Precision Peptide Genetic Test is $298 — adding pathway-level genetic context most telehealth-only programs do not include.

Continue in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education